Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Flow Cytometry Rapidly Determines Specific Interleukin-6 Activity

By LabMedica International staff writers
Posted on 29 Oct 2014
The measurement of the specific activity of a given cytokine often requires a time-consuming and tedious bioassay based upon its effect on the proliferation, chemotaxis, or toxicity of a factor-dependent cell line.

The determination of the specific activity of the cytokine interlukin-6 (IL-6) was accomplished by ascertaining the dose–response curve of the phosphorylation of a signaling protein that can be quantified by flow cytometry.

Immunologists at Héma-Québec (Montreal, QC, Canada) used the IL-6 model, as an approach for the determination of the specific activity of cytokines by determining the dose–response curve of the phosphorylation of the signaling protein Stat-3 pY705 for IL-6, in a responsive cell line subjected to different concentrations of the cytokine. More...
The phosphorylation of the protein is quantified by flow cytometry. Since the signaling cascade only takes a few minutes to achieve following linking of the cytokine to its receptor, the whole procedure can be done in a few hours.

The scientists used the cell line 7TD1 (DSMZ, German Collection of Microorganisms and Cell Cultures GmbH; Braunschweig, Germany), which is an IL-6 dependent cell line. The cells were cultured in RPMI-1640 containing 5% fetal bovine serum (FBS) and 10 ng/mL of IL-6. To speed up flow cytometry, the samples were fluorescently barcoded by adding Pacific Blue and Alexa Fluor 488 to allow multiplex analysis. After processing the cells were analyzed on a Partec CyFlow ML flow cytometer (Swedesboro, NJ, USA).

The scientists were able to determine and compare the specific activity of commercial lots of IL-6 using the flow cytometry method. They observed significant differences both from lots from different manufacturers and lots from a same manufacturer, with an eightfold difference between the specific activity of the highest and lowest one. This demonstrated that in studies requiring accurate cytokine concentrations, determining the specific activity for each lot should be a crucial step in order to get reproducible results.

Higher levels of IL-6 have been observed in the blood of advanced or metastatic cancer patients and are associated with the development of encephalitis in children. The study was published on October 5, 2014, in the Journal of Immunological Methods.

Related Links:

Héma-Québec
German Collection of Microorganisms and Cell Cultures GmbH 
Partec



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.